Morphic Aktie
WKN DE: A2PLX9 / ISIN: US61775R1059
19.03.2024 13:50:56
|
Morphic Appoints Simon Cooper As Chief Medical Officer
(RTTNews) - Morphic Holding, Inc. (MORF) on Tuesday announced the appointment of Simon Cooper as the Chief Medical Officer.
With a background in immunology and inflammatory diseases, Cooper brings extensive expertise as a clinical development leader. Prior to this role, Cooper held the position of Chief Medical Officer at Keros Therapeutics.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Morphic Holding Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |